JP4630102B2 - Hyaluronic acid production promoter and cosmetics containing the same - Google Patents
Hyaluronic acid production promoter and cosmetics containing the same Download PDFInfo
- Publication number
- JP4630102B2 JP4630102B2 JP2005099935A JP2005099935A JP4630102B2 JP 4630102 B2 JP4630102 B2 JP 4630102B2 JP 2005099935 A JP2005099935 A JP 2005099935A JP 2005099935 A JP2005099935 A JP 2005099935A JP 4630102 B2 JP4630102 B2 JP 4630102B2
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- acid production
- same
- appropriate amount
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims description 13
- 229920002674 hyaluronan Polymers 0.000 title claims description 13
- 229960003160 hyaluronic acid Drugs 0.000 title claims description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000002537 cosmetic Substances 0.000 title description 16
- 244000280244 Luffa acutangula Species 0.000 claims description 3
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 11
- 241000219104 Cucurbitaceae Species 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229940092309 pumpkin seed extract Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 240000004244 Cucurbita moschata Species 0.000 description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 description 3
- 102000018866 Hyaluronan Receptors Human genes 0.000 description 3
- 108010013214 Hyaluronan Receptors Proteins 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000408747 Lepomis gibbosus Species 0.000 description 2
- -1 Polyoxyethylene cetyl ether Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- 235000020236 pumpkin seed Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000219138 Luffa Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000949476 Toona Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Description
本発明は、ケラチノサイトのヒアルロン酸産生を促進することにより、皮膚のハリ・シワの改善を目的とした化粧料に関する。 The present invention relates to a cosmetic intended to improve the skin wrinkles and wrinkles by promoting hyaluronic acid production of keratinocytes.
近年、高齢化社会が進行するにつれて、美しく年を重ねるために、化粧品に求められる役割が大きくなってきている。ところが、肌は、加齢等の内的因子や紫外線、活性酸素等の外的因子によって、皮膚が本来維持している収縮性、柔軟性、保湿性等の機能が衰え、様々なトラブルを発生する。 In recent years, as the aging society progresses, the role required for cosmetics has been increasing in order to beautifully grow older. However, due to internal factors such as aging and external factors such as ultraviolet rays and active oxygen, the skin's inherent functions such as contractility, flexibility, and moisture retention decline, causing various problems. To do.
これらのトラブルの一つであるシワは、真皮の細胞外マトリックスを産生する細胞数の減少、分裂速度の衰え等による細胞機能の老化や、コラーゲン線維の減少及び変性、皮下脂肪組織の減少等により、皮膚の弛緩及び弾力性の損失の起こることが原因となって発生する。 Wrinkles, one of these troubles, are caused by a decrease in the number of cells that produce the extracellular matrix of the dermis, aging of cell functions due to a decrease in division rate, decrease and degeneration of collagen fibers, decrease of subcutaneous adipose tissue, etc. Occurs due to the occurrence of skin relaxation and loss of elasticity.
従来、皮膚老化への対処法としては、老化によって失われるコラーゲン、ヒアルロン酸等の物質を皮膚に塗布し補う組成物や、紫外線や活性酸素から皮膚を守るための防御物質を配合した間接的な老化防止剤が主流であった。しかしながら、これらの方法は満足のいく効果を奏するものではなかった。また、老化特に生成したシワを根本的に改善しようとする試みとしてはレチノイン酸(特開2005−15388)やグリコール酸に代表されるα−ヒドロキシ酸等(特開平8−259420,特開平9−301883)があるが、これらは高い配合量が必要とされ、腫れを伴う炎症等を起こす等安全性に問題があり、長期使用に耐え得るものではなかった。
解決しようとする問題点は、皮膚の老化を根本的に改善し、しかも皮膚に弊害がなく、安全に使用できる老化防止に有効な化粧料の提供である。 The problem to be solved is to provide a cosmetic material that can fundamentally improve the aging of the skin, has no harmful effects on the skin, and can be used safely and is effective in preventing aging.
そこで本発明者は、係る実情に鑑み鋭意検討した結果、ウリ科植物の種子から得られた抽出物が、ケラチノサイトのヒアルロン酸産生能を活性化し、細胞外マトリックスの産生を増加させることにより、皮膚のハリ・シワの改善に顕著な作用を示すことを見出し、本発明を完成するに至った。 Therefore, as a result of intensive studies in view of the actual situation, the present inventors have found that the extract obtained from the seeds of the cucurbitaceae plant activates the hyaluronic acid producing ability of keratinocytes and increases the production of extracellular matrix, thereby reducing the skin. As a result, the present invention has been completed.
即ち、本発明は、ウリ科植物の種子から得られた抽出物を含有することを特徴とする老化防止に有効な皮膚外用剤を提供するものである。 That is, this invention provides the skin external preparation effective for anti-aging characterized by including the extract obtained from the seed of the Cucurbitaceae plant.
本発明で使用されるウリ科植物の種子は、特に限定はされないが、カボチャ(Cucurbita moschata Duch. var. Toonas Makino)、ヘチマ(Luffa cylindrical Roem.)の種子が好ましい。そして、抽出方法も特に限定は無く、通常、各種溶剤で抽出し、抽出物(エキス)を精製することにより得ることができる。 The seeds of the Cucurbitaceae plant used in the present invention are not particularly limited, but pumpkin (Cucurbita moschata Duch. Var. Toonas Makino) and loofah (Luffa cylindrical Roem.) Seeds are preferred. The extraction method is also not particularly limited, and can usually be obtained by extracting with various solvents and purifying the extract (extract).
即ち、ウリ科植物の種子から得られた抽出物は、抽出溶媒としては、水、各種極性有機溶媒及びそれらの混液、及び塩酸酸性にした極性溶媒を用いることができる。 That is, the extract obtained from the seeds of Cucurbitaceae plants can use water, various polar organic solvents and mixtures thereof, and a polar solvent acidified with hydrochloric acid as an extraction solvent.
本発明に係るウリ科植物の種子から得られた抽出物の各種化粧料に対する配合量は、化粧料の実施態様、化粧料の使用形態等に応じて変動させることができるので特に限定されない。原則的には、有効量存在すれば良いことになるが、一般的には化粧料組成物中、乾燥重量に換算して0.0001〜100質量%が利用でき、好ましくは0.01〜10質量%、更に好ましくは0.1〜5.0質量%である。 The blending amount of the extract obtained from the seeds of the Cucurbitaceae plant according to the present invention with respect to various cosmetics is not particularly limited because it can be varied according to the cosmetic embodiment, cosmetic usage form, and the like. In principle, an effective amount may be present, but generally 0.0001 to 100% by mass in terms of dry weight can be used in a cosmetic composition, preferably 0.01 to 10%. It is 0.1 mass%, More preferably, it is 0.1-5.0 mass%.
本発明に係る化粧料の適用範囲は、特に限定されない。つまり、この発明の有効成分が有する作用効果に応じて各作用効果を利用できる全ての化粧料に適用できる。 The application range of the cosmetic according to the present invention is not particularly limited. That is, the present invention can be applied to all cosmetics that can use each function and effect according to the function and effect of the active ingredient of the present invention.
例えば、本発明に係る有効成分を各種化粧料基剤等に配合して、クリーム、乳液、化粧水、パック剤、洗顔料等の各種基礎化粧料、ファンデーション、口紅、ほほ紅、白粉等の各種メーキャップ料、洗髪料、養毛剤、シャンプー、リンス等の各種頭髪用化粧料、石鹸、美爪料、オーデコロン等その他化粧料に対して広範囲に適用できる。また、前記各種化粧料の実施態様は、ローション、エマルジョン、軟膏、ゾル、ゲル、パウダー、スプレー、固形等の各種態様で適用できる。 For example, the active ingredient according to the present invention is blended in various cosmetic bases, and various basic cosmetics such as creams, emulsions, lotions, packs, facial cleansers, foundations, lipsticks, cheeks, white powders, etc. It can be applied to a wide range of cosmetics such as makeup, hair washing, hair nourishing agents, shampoos and rinses, and other cosmetics such as soaps, beauty nails and eau de cologne. Moreover, the embodiment of the various cosmetics can be applied in various forms such as lotion, emulsion, ointment, sol, gel, powder, spray, and solid.
以下、実施例により本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited to these.
〔実施例1〕カボチャ種子から得られるエキスの作成
原材料として、カボチャ種子の種皮を除いた胚乳を50g使用した。前記原材料50gにイオン交換水200mlを加え、60℃で6時間加熱抽出した後上澄みを遠心分離し、比較的大きい浮遊物を除去したあと、メッシュ径0.22μmのろ紙を用いてろ過する。ロータリーエバポレーターにて減圧濃縮し、カボチャ種子エキス約0.5gを得た。
[Example 1] As a raw material for preparing an extract obtained from pumpkin seeds, 50 g of endosperm excluding the seed coat of pumpkin seeds was used. After adding 200 ml of ion-exchanged water to 50 g of the raw material and heating and extracting at 60 ° C. for 6 hours, the supernatant is centrifuged to remove relatively large suspended matter, and then filtered using a filter paper having a mesh diameter of 0.22 μm. Concentration under reduced pressure using a rotary evaporator gave about 0.5 g of pumpkin seed extract.
〔実施例2〕ケラチノサイトを用いたヒアルロン酸産生試験
(1)試験溶液調製
前記カボチャ種子エキスを5%牛胎児血清含有DULBECCO’S MODIFICATION OF EAGLE’S MEDIUM(EME)培地に1.0(w/v)%になるように溶解後、0.2μmメンブランフィルターにて濾過滅菌し、適宜希釈したものを、試験溶液とした。
(2)細胞培養
ケラチノサイトを、DULBECCO’S-EME培地に5(v/v)%の牛胎児血清を添加したもので培養した。前記培地にて5×105cell/mLに調整した細胞を、内径6.5mmの滅菌プラスチック96穴プレートに0.1mLずつ接種し、48時間培養した。
(3)培地内ヒアルロン酸の定量
ヒアルロン酸の定量は生化学工業株式会社製のヒアルロン酸測定キットを用いた。培養した細胞から培地を取りだし、ヒアルロン酸結合蛋白質(HABP)が固定化されたマイクロプレートに50μL添加した。続いて、ビオチン標識HABP溶液を各ウェルあたり、50μLずつ添加した。プレートミキサーを用い、1分間混和後、37℃で60分間静置した。(1時反応)各ウェルの洗浄後HRP標識ストレプトアビジン溶液を100μLずつ添加した後、37℃で60分間静置した。(2次反応)各ウェルの洗浄後、酵素基質溶液を100μLずつ添加した後、アルミホイルなどで遮光し常温で30分間静置した。(発光反応)各ウェルに反応停止溶液を100μLずつ添加した。プレートリーダーで各ウェルの吸光度を測定した。
[Example 2] Hyaluronic acid production test using keratinocytes (1) Preparation of test solution The pumpkin seed extract was added to 1.0% (w / v)% in DULBECCO'S MODIFICATION OF EAGLE'S MEDIUM (EME) medium containing 5% fetal bovine serum. After dissolution, the solution was sterilized by filtration through a 0.2 μm membrane filter and appropriately diluted to obtain a test solution.
(2) Cell culture Keratinocytes were cultured in DULBECCO'S-EME medium supplemented with 5 (v / v)% fetal bovine serum. Cells adjusted to 5 × 10 5 cells / mL in the above medium were inoculated into 0.1 mL each in a sterile plastic 96-well plate with an inner diameter of 6.5 mm and cultured for 48 hours.
(3) Quantification of hyaluronic acid in culture medium Hyaluronic acid was quantified using a hyaluronic acid measurement kit manufactured by Seikagaku Corporation. The medium was taken out from the cultured cells, and 50 μL was added to a microplate on which hyaluronic acid binding protein (HABP) was immobilized. Subsequently, 50 μL of biotin-labeled HABP solution was added to each well. After mixing for 1 minute using a plate mixer, the mixture was allowed to stand at 37 ° C. for 60 minutes. (1 hour reaction) After washing each well, 100 μL each of HRP-labeled streptavidin solution was added, and then allowed to stand at 37 ° C. for 60 minutes. (Secondary reaction) After washing of each well, 100 μL of enzyme substrate solution was added, and then light-shielded with aluminum foil or the like and allowed to stand at room temperature for 30 minutes. (Luminescence reaction) 100 μL of a reaction stop solution was added to each well. The absorbance of each well was measured with a plate reader.
レチノイン酸およびウリ科種子エキスのケラチノサイトにおけるヒアルロン酸産生能を表1に示す。 Table 1 shows the hyaluronic acid producing ability in keratinocytes of retinoic acid and cucurbitaceae seed extract.
表1の結果より、ウリ科種子エキスは高いヒアルロン酸産生を促進する効果を有するとされているレチノイン酸にはおよばないものの明らかにヒアルロン酸産生を促進することが判明した。 From the results shown in Table 1, it was found that the cucurbitaceae seed extract clearly promotes hyaluronic acid production although it does not reach retinoic acid, which is said to have an effect of promoting high hyaluronic acid production.
以下に本発明の処方例を挙げる。
<処方例1>化粧水
(成分名) (質量%)
カボチャ種子エキス 0.01
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
エタノール 10.0
防腐剤・酸化防止剤 適量
香料 適量
精製水 残部
The formulation example of this invention is given to the following.
<Formulation example 1> lotion (component name) (mass%)
Pumpkin seed extract 0.01
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Ethanol 10.0
Antiseptic / Antioxidant Appropriate amount of perfume Appropriate amount of purified water Remainder
<処方例2>クリーム
(成分名) (質量%)
カボチャ種子エキス 0.0001
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
グリセリン 5.0
水酸化カリウム 0.3
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Formulation example 2> Cream (component name) (mass%)
Pumpkin seed extract 0.0001
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
Glycerin 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例3>乳液
(成分名) (質量%)
カボチャ種子エキス 0.1
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
グリセリン 1.5
水酸化カリウム 0.1
エタノール 7.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 3> Emulsion (component name) (mass%)
Pumpkin seed extract 0.1
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Glycerin 1.5
Potassium hydroxide 0.1
Ethanol 7.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例4>パック剤
(成分名) (質量%)
カボチャ種子エキス 0.01
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
エタノール 5.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 4> Packing agent (component name) (mass%)
Pumpkin seed extract 0.01
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Ethanol 5.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例5>軟膏
(成分名) (質量%)
カボチャ種子エキス 0.0001
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 5> Ointment (component name) (mass%)
Pumpkin seed extract 0.0001
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例6>パウダーファンデーション
(成分名) (質量%)
カボチャ種子エキス 0.01
タルク 43.0
カオリン 18.0
マイカ 8.0
酸化亜鉛 10.0
酸化チタン 5.0
着色顔料 適量
ステアリン酸マグネシウム 6.0
流動パラフィン 4.0
白色ワセリン 1.0
セレシン 1.0
ミリスチン酸イソプロピル 1.5
防腐剤・酸化防止剤 適量
香料 適量
<Formulation example 6> Powder foundation (component name) (mass%)
Pumpkin seed extract 0.01
Talc 43.0
Kaolin 18.0
Mica 8.0
Zinc oxide 10.0
Titanium oxide 5.0
Coloring pigment Appropriate amount Magnesium stearate 6.0
Liquid paraffin 4.0
White petrolatum 1.0
Ceresin 1.0
Isopropyl myristate 1.5
Preservative / Antioxidant Appropriate amount Perfume Appropriate amount
処方例2のクリームを健常成人女性20名に1ヶ月間使用させたところ、18名に皮膚の潤い及びハリ、シワが改善したとの結果を得た。また、使用中に肌に何らかの異常を感じたパネラーは無かった。 When 20 healthy adult women were allowed to use the cream of Prescription Example 2 for 1 month, 18 people obtained a result that skin moisture, firmness and wrinkles were improved. In addition, no panelists felt any abnormality on the skin during use.
本発明によれば、ウリ科種子エキス、特にカボチャ及びヘチマの種子抽出物に高いヒアルロン酸産生促進効果が見られることから、それを含有させることにより、高い安全性を有したシワ改善に有効な化粧料の提供が期待できる。
According to the present invention, since a high hyaluronic acid production promoting effect is seen in the seed extract of Cucurbitaceae seed extract, particularly pumpkin and loofah, it is effective to improve wrinkles with high safety by containing it. Providing cosmetics can be expected.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005099935A JP4630102B2 (en) | 2005-03-30 | 2005-03-30 | Hyaluronic acid production promoter and cosmetics containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005099935A JP4630102B2 (en) | 2005-03-30 | 2005-03-30 | Hyaluronic acid production promoter and cosmetics containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006273815A JP2006273815A (en) | 2006-10-12 |
JP4630102B2 true JP4630102B2 (en) | 2011-02-09 |
Family
ID=37208900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005099935A Active JP4630102B2 (en) | 2005-03-30 | 2005-03-30 | Hyaluronic acid production promoter and cosmetics containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4630102B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210023155A (en) * | 2019-08-22 | 2021-03-04 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5690102B2 (en) * | 2010-08-28 | 2015-03-25 | アサマ化成株式会社 | Composition for preventing and treating urological diseases and method for producing the same |
KR101256180B1 (en) | 2011-07-25 | 2013-04-19 | 동의대학교 산학협력단 | Cosmetic composition comprising extract of thin film outer cover of Luffa Roemer seed for skin whitening |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6253911A (en) * | 1985-09-02 | 1987-03-09 | Shiseido Co Ltd | Cosmetic |
JPH06234648A (en) * | 1992-12-09 | 1994-08-23 | Indena Spa | Novel extract from cucurbitaseed, its production, and its use in drugs and cosmetics |
JP2001316263A (en) * | 1991-02-28 | 2001-11-13 | Parfums Dior Christian | Use of cucurbitine for preparing antiallergic composition for cosmetic or medicine especially for dermatology, and method including administration thereof |
JP2003171225A (en) * | 2001-11-30 | 2003-06-17 | Fancl Corp | COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION |
JP2003226655A (en) * | 2002-01-31 | 2003-08-12 | Fancl Corp | COMPOSITION CONTAINING LAMININ-5 PRODUCTION PROMOTER AND INTEGRIN-alpha6beta4 PRODUCTION PROMOTER |
JP2003528123A (en) * | 2000-03-24 | 2003-09-24 | インデナ・ソチエタ・ペル・アチオニ | Cosmetic composition having a delay effect on the regeneration of unwanted hair |
JP2005015409A (en) * | 2003-06-27 | 2005-01-20 | Kanebo Cosmetics Inc | Hair growth-suppressive skin preparation for external use |
JP2005502612A (en) * | 2001-06-29 | 2005-01-27 | ラボラトワール エクスパンシアンス | Use of cucurbitaceae oil for inhibition of 5α-reductase activity |
-
2005
- 2005-03-30 JP JP2005099935A patent/JP4630102B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6253911A (en) * | 1985-09-02 | 1987-03-09 | Shiseido Co Ltd | Cosmetic |
JP2001316263A (en) * | 1991-02-28 | 2001-11-13 | Parfums Dior Christian | Use of cucurbitine for preparing antiallergic composition for cosmetic or medicine especially for dermatology, and method including administration thereof |
JPH06234648A (en) * | 1992-12-09 | 1994-08-23 | Indena Spa | Novel extract from cucurbitaseed, its production, and its use in drugs and cosmetics |
JP2003528123A (en) * | 2000-03-24 | 2003-09-24 | インデナ・ソチエタ・ペル・アチオニ | Cosmetic composition having a delay effect on the regeneration of unwanted hair |
JP2005502612A (en) * | 2001-06-29 | 2005-01-27 | ラボラトワール エクスパンシアンス | Use of cucurbitaceae oil for inhibition of 5α-reductase activity |
JP2003171225A (en) * | 2001-11-30 | 2003-06-17 | Fancl Corp | COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION |
JP2003226655A (en) * | 2002-01-31 | 2003-08-12 | Fancl Corp | COMPOSITION CONTAINING LAMININ-5 PRODUCTION PROMOTER AND INTEGRIN-alpha6beta4 PRODUCTION PROMOTER |
JP2005015409A (en) * | 2003-06-27 | 2005-01-20 | Kanebo Cosmetics Inc | Hair growth-suppressive skin preparation for external use |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210023155A (en) * | 2019-08-22 | 2021-03-04 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
KR102294967B1 (en) | 2019-08-22 | 2021-08-30 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
Also Published As
Publication number | Publication date |
---|---|
JP2006273815A (en) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2689767B1 (en) | Methods for improving the condition and appearance of skin | |
JP6387219B2 (en) | Skin external preparation composition containing tangeretin and EGCG | |
TW201206494A (en) | Use of Tiliacora triandra in cosmetics and compositions thereof | |
KR101663946B1 (en) | Cosmetic composition containing an ginsenoside Rg3 reinforced extract of fermentative Ginseng flower(Panax ginseng C. A. Meyer) by Aureobasidium pullulans | |
KR100824212B1 (en) | Composition for skin protection containing placenta and preparation method thereof | |
JP3696862B2 (en) | Method of using moisturizer and plant extract, and external preparation | |
JP4630102B2 (en) | Hyaluronic acid production promoter and cosmetics containing the same | |
RU2675702C1 (en) | Composition for reducing skin ageing disorders, comprising retinaldehyde and leontopodium alpinum extract | |
KR101605324B1 (en) | Cosmetic composition for moisturizing skin which alleviates itchiness and dryness by removing keratin and increasing moisture | |
KR100794518B1 (en) | A cosmetic composition containing a extract of Viola tricolor L. | |
JP2004067552A (en) | Collagen production promoter, and cosmetic containing the same | |
JP2006273822A (en) | Cosmetic containing clear liquor (shochu) lees | |
CN109172514A (en) | A kind of skin care item and preparation method thereof of moisturizing anti-aging | |
KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
KR20100067700A (en) | Cosmetic compositions for skin care containing extract of tussilago farfara linne flower | |
CN106265211B (en) | Cistanche salsa supernatant mixture, preparation method thereof and skin barrier repair effect thereof | |
JP2008247787A (en) | External preparation for skin | |
JP2003128573A (en) | Hyaluronic acid production stimulator, and skin care preparation containing the same | |
JP7485336B2 (en) | MSX-2 mRNA expression promoter, eyelash growth agent, and external preparation composition for eyelash growth | |
KR102468538B1 (en) | Skin improvement composition containing wild geranium extract with excellent antioxidant, whitening and anti-inflammatory effects | |
TWI788019B (en) | Use of chamaemelum nobile extract for manufacturing skincare composition | |
EP1009378A1 (en) | Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology | |
KR20140083424A (en) | Cosmetic composition for cutis elastica or skin-moisture containing eriodictyol | |
KR20190025578A (en) | Cosmetic composition for cutis elastica or skin-moisture containing eriodictyol | |
KR20170023911A (en) | Cosmetic composition for cutis elastica or skin-moisture containing eriodictyol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080229 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100810 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101008 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101102 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101112 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131119 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4630102 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |